|
|
.
See Category: Factors influencing health status and contact with health services
See Header: Encounter for adjustment or removal of breast implant
ICD-10 (CM) Code and Descriptor
|
Z45.812 |
Encounter for adjustment or removal of left breast implant
|
Z45812 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 46.23%
|
34.83%
|
5.17%
|
3.18%
|
4.24%
|
2.25%
|
0.66%
|
0.53%
|
0.40%
|
0.93%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for Z45.812*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
220
|
929
|
|
J3010
|
FENTANYL CITRATE INJECTION |
219
|
396
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
212
|
7,389
|
|
J2405
|
ONDANSETRON HCL INJECTION |
199
|
902
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
177
|
1,166
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
132
|
271
|
|
C1789
|
PROSTHESIS, BREAST, IMP |
131
|
195
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
116
|
376
|
|
11970
|
RPLCMT TISS XPNDR PERM IMPLT |
110
|
110
|
|
88300
|
SURGICAL PATH GROSS |
106
|
128
|
|
J1170
|
HYDROMORPHONE INJECTION |
93
|
154
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
92
|
286
|
|
J1580
|
GARAMYCIN GENTAMICIN INJ |
92
|
131
|
|
J7120
|
RINGERS LACTATE INFUSION |
92
|
124
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
89
|
89
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
73
|
99
|
|
J2001
|
LIDOCAINE INJECTION |
66
|
946
|
|
J2370
|
PHENYLEPHRINE HCL INJECTION |
52
|
395
|
|
J2710
|
NEOSTIGMINE METHYLSLFTE INJ |
47
|
290
|
|
88304
|
TISSUE EXAM BY PATHOLOGIST |
47
|
60
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
Z45.812 related to the following DRG Codes:
951
|
